Author

Frits Koning

ABERRANT INTRA-EPITHELIAL LYMPHOCYTES CAUSE VILLOUS ATROPHY IN REFRACTORY CELIAC DISEASE TYPE II BY GRANZYME-B-INDUCED APOPTOSIS OF ENTEROCYTES MEDIATED VIA CD103(αE)β7-E-CADHERIN-INTERACTIONS

Daan A.R. Castelijn, Jolanda M.W. van de Water, Bridget McGlinchy, Michelle van Leeuwen, Laura R de Baaij, Martine Reijm, Jolien Hollander, Yvonne Kooy-Winkelaar, Frits Koning, Gerd Bouma, Chris J.L.M. Meijer, Hetty J Bontkes, Chris J.J. Mulder, Saskia A.G.M. Cillessen

From "at risk" to clinical manifestions: Understanding the pathophysiology

Frits Koning

HLA-DR+CD38+ EFFECTOR T HELPER CELLS DISTINGUISH CROHN’S DISEASE-ASSOCIATED PERIANAL FISTULAS FROM CRYPTOGLANDULAR FISTULAS

Laura F. Ouboter, Mette Schreurs, Tamim R. M. Abdelaal, Sietse J. Luk, Marieke Barnhoorn, Willem E. Hueting, Ingrid J. M. Han-Geurts, Koen C. M. J. Peeters, Fabian A. Holman, Frits Koning, Andrea E. Van Der Meulen - De Jong, Fernanda Pascutti

LOCALLY INJECTED ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF REFRACTORY PROCTITIS: PRELIMINARY RESULTS OF A PHASE IIA TRIAL

Leonie G. Plug, Melissa van Pel, Jaap J. Zwaginga, Lukas J.A.C. Hawinkels, Dave Roelen, M. Fernanda Pascutti, Frits Koning, Hein W. Verspaget, Laura F. Ouboter, Marieke Barnhoorn, Andrea E. Van Der Meulen - De Jong

New therapeutics beyond gluten elimination

Frits Koning

Item 1 - 5 / 10
1